The Biotech Growth Trust PLC (BIOG)

Category Sector Equity Biotechnology

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.

Sell

836.00p

Buy

840.00p

arrow-up2.00p (+0.24%)

Discount/Premium

-12.74%

Estimated NAV

962.60p

Prices updated at 17 Jan 2025, 16:35 GMT

Prices minimum 15 mins delay

Prices in GBX

Investment objective

The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.

FTSE All-Share

1.21%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

In the news

Sharecast service unavailable

Press releases

17 Jan 2025

16 Jan 2025

15 Jan 2025

14 Jan 2025

13 Jan 2025

10 Jan 2025

Key dates

	Forecast date
Half yearly results	Nov 2025
Annual general meeting	Jul 2025
Final results	Jun 2025
Annual report	Jun 2025

	Previous date
Half yearly results	Nov 2024
Annual general meeting	Jul 2024
Final results	Jun 2024
Annual report	Jun 2024

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.